Activity of oral agents against pediatric isolates of Streptococcus pneumoniae

被引：3
|
作者：
Black, J
Moland, ES
Chartrand, SA
Thomson, KS
机构：
[1] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Ctr Res Anti Infect & Biotechnol, Omaha, NE 68178 USA
[2] Creighton Univ, Sch Med, Dept Pediat Infect Dis, Omaha, NE 68178 USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2001年 / 39卷 / 03期
关键词：
D O I：
10.1016/S0732-8893(01)00209-7
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
An in vitro study of the activity of 10 oral agents against 153 pediatric isolates of Streptococcus pneumoniae identified moxifloxacin and levofloxacin as the most active agents regardless of penicillin or macrolide susceptibility. Moxifloxacin inhibited all strains at 0.25 mug/ml and was 8- to 16-fold more potent than levofloxacin. (C) 2001 Elsevier Science inc. All rights reserved.
引用
收藏
页码：195 / 197
页数：3
相关论文
共 50 条
  • [21] Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 250 invasive Streptococcus pneumoniae isolates from France
    Decousser, JW
    Pina, P
    Picot, F
    Allouch, PY
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (09) : 561 - 565
  • [22] Comparative In Vitro Activity of Faropenem and 11 Other Antimicrobial Agents Against 250 Invasive Streptococcus pneumoniae Isolates from France
    J. W. Decousser
    P. Pina
    F. Picot
    P. Y. Allouch
    European Journal of Clinical Microbiology and Infectious Diseases , 2003, 22 : 561 - 565
  • [23] In Vitro Antimicrobial Activity of Cefditoren against Streptococcus pneumoniae and Haemophilus influenzae Clinical Isolates
    Kim, Nam Joong
    Kim, Sung Hye
    Kim, Mi Young
    Jun, Jae Bum
    Park, Su Jin
    Kwak, Yee Gyung
    Jeong, Jin-Yong
    Choi, Sang-Ho
    Woo, Jun Hee
    Ryu, Jiso
    Kim, Yang Soo
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S83 - S83
  • [24] Comparative in vitro activity and pharmacodynamics of five fluoroquinolones against clinical isolates of Streptococcus pneumoniae
    Kays, MB
    Conklin, M
    PHARMACOTHERAPY, 2000, 20 (11): : 1310 - 1317
  • [25] In-vitro activity of a combination of two oral β-lactams (cefpodoxime and amoxycillin) against Streptococcus pneumoniae isolates with reduced susceptibilities to penicillin
    Johnson, DM
    Jones, RN
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (04) : 555 - 557
  • [26] Antimicrobial activity of sodium citrate against Streptococcus pneumoniae and several oral bacteria
    Nagaoka, S.
    Murata, S.
    Kimura, K.
    Mori, T.
    Hojo, K.
    LETTERS IN APPLIED MICROBIOLOGY, 2010, 51 (05) : 546 - 551
  • [27] In vitro activity of gemifloxacin (SB-265805) compared to eleven other antimicrobial agents against streptococcal isolates, excluding Streptococcus pneumoniae
    Kerawala M.
    Ambler J.E.
    Lee P.Y.C.
    Drabu Y.J.
    European Journal of Clinical Microbiology and Infectious Diseases, 2001, 20 (4): : 271 - 275
  • [28] In vitro activity of gemifloxacin (SB-265805) compared to eleven other antimicrobial agents against streptococcal isolates, excluding Streptococcus pneumoniae
    Kerawala, M
    Ambler, JE
    Lee, PYC
    Drabu, YJ
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (04) : 271 - 275
  • [29] Moxifloxacin:: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae
    Reinert, RR
    Schlaeger, JJ
    Lütticken, R
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (06) : 803 - 806
  • [30] Activity of ceftobiprole against Streptococcus pneumoniae isolates exhibiting high-level resistance to ceftriaxone
    Davies, Todd A.
    Flamm, Robert K.
    Lynch, A. Simon
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (06) : 534 - 538
12345